News
We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the ...
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...
HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and ...
5h
ABP News on MSNDelhi CM Rekha Gupta Launches HIMS, 34 Ayushman Mandirs To Digitize Delhi HealthcareCM Rekha Gupta launched Delhi’s expanded digital Health Information Management System, 34 Ayushman Mandirs, and 8 Jan Aushadhi Kendras, promising faster, transparent and accessible public healthcare.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
2d
Zacks.com on MSNHims & Hers Paves the Way for Global Digital Health ExpansionHIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.
The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...
The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...
Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results